ALPINE IMMUNE SCIENCES, INC. Net Income (Loss) Available to Common Stockholders, Basic
ALPINE IMMUNE SCIENCES, INC. reported Net Income (Loss) Available to Common Stockholders, Basic of -$8.92 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-02.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2017-05-02
- ALPINE IMMUNE SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-03-31 was -$8.92M.
- ALPINE IMMUNE SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-12-31 was -$7.71M.
- ALPINE IMMUNE SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-09-30 was -$7.43M.
- ALPINE IMMUNE SCIENCES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-06-30 was -$8.48M.
- ALPINE IMMUNE SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2016 was -$31.46M.
- ALPINE IMMUNE SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2015 was -$22.82M.
- ALPINE IMMUNE SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2014 was -$15.04M.
- ALPINE IMMUNE SCIENCES, INC. net income (loss) available to common stockholders, basic for fiscal 2013 was -$16.20M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$8.92M 10-Q · filed 2017-05-02 | -$16.63M derived: sum of 2 quarters · filed 2017-05-02 | -$24.06M derived: sum of 3 quarters · filed 2017-05-02 | -$32.54M derived: sum of 4 quarters · filed 2017-05-02 |
| 2016-12-31 | -$7.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | -$15.15M derived: sum of 2 quarters · filed 2017-02-13 | -$23.63M derived: sum of 3 quarters · filed 2017-02-13 | -$31.46M 10-K · filed 2017-02-13 |
| 2016-09-30 | -$7.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$15.91M derived: sum of 2 quarters · filed 2016-11-07 | -$23.75M 10-Q · filed 2016-11-07 | -$30.31M derived: sum of 4 quarters · filed 2017-05-02 |
| 2016-06-30 | -$8.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$16.32M 10-Q · filed 2016-08-02 | -$22.88M derived: sum of 3 quarters · filed 2017-05-02 | -$28.97M derived: sum of 4 quarters · filed 2017-05-02 |
| 2016-03-31 | -$7.84M 10-Q · filed 2017-05-02 | -$14.40M derived: sum of 2 quarters · filed 2017-05-02 | -$20.49M derived: sum of 3 quarters · filed 2017-05-02 | -$26.34M derived: sum of 4 quarters · filed 2017-05-02 |
| 2015-12-31 | -$6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | -$12.65M derived: sum of 2 quarters · filed 2017-02-13 | -$18.50M derived: sum of 3 quarters · filed 2017-02-13 | -$22.82M 10-K · filed 2017-02-13 |
| 2015-09-30 | -$6.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$11.94M derived: sum of 2 quarters · filed 2016-11-07 | -$16.25M 10-Q · filed 2016-11-07 | -$19.74M derived: sum of 4 quarters · filed 2017-02-13 |
| 2015-06-30 | -$5.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$10.17M 10-Q · filed 2016-08-02 | -$13.65M derived: sum of 3 quarters · filed 2017-02-13 | -$16.66M derived: sum of 4 quarters · filed 2017-02-13 |
| 2015-03-31 | -$4.31M 10-Q · filed 2016-05-03 | -$7.80M derived: sum of 2 quarters · filed 2017-02-13 | -$10.81M derived: sum of 3 quarters · filed 2017-02-13 | |
| 2014-12-31 | -$3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | -$6.50M derived: sum of 2 quarters · filed 2017-02-13 | -$15.04M 10-K · filed 2017-02-13 | |
| 2014-09-30 | -$3.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$11.55M 10-Q · filed 2015-11-03 | ||
| 2014-06-30 | -$8.54M 10-Q · filed 2015-08-04 | |||
| 2013-12-31 | -$16.20M 10-K · filed 2016-03-08 |